New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics, expected to benefi [...]Read more
Spectronaut 17 features directDIA+™, the best-performing library-free workflow for DIA proteomics available on the market.Read more
A growing number of scientific publications have been using Biognosys' technology and tools in the first half of 2022.Read more
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today that they are participating in the ALDA (Analytical, Life Science &a [...]Read more
The expansion is part of the company’s growth strategy for North America and will foster collaboration with life science companies and academia. An inauguration event will take p [...]Read more
Biognosys announced today that they are participating in the upcoming Capital One Spatial Biology & Proteomics Healthcare Disruptors Summit, taking place virtually on Wednesday, Se [...]Read more
Access our knowledge base with relevant resources and guiding information.